Nigerian COVID-19 response highlights cultural trust in ethnopharmacology

Throughout COVID-19, ethnopharmacology grew to become distinguished in Nigeria on account of affordability, accessibility, and cultural belief, however proof for security and efficacy stays restricted. This evaluate examines ethnopharmacology’s integration into Nigeria’s COVID-19 response, evaluating strengths, constraints, and future pathways. Widespread treatments included ginger, garlic, lemon, turmeric, and bitter kola. NAFDAC listed 14 natural medicines based mostly on toxicological security, however efficacy requires rigorous trials. Some formulations confirmed promising preliminary outcomes, however proof was constrained by small samples, lack of RCTs, and inadequate pharmacokinetic knowledge. Strengthening resilience requires analysis funding, IP frameworks, and clear communication.

Introduction

COVID-19, first reported in Wuhan in November 2019, prompted over 500 million instances globally inside three years. Nigeria’s first case was on February 27, 2020. The pandemic uncovered healthcare inequities and renewed curiosity in ethnopharmacology. In Nigeria, ~80% depend on natural treatments. Widespread crops included ginger, garlic, lemon, and neem. NAFDAC and NIPRD accelerated analysis of 14 natural medicines.

Conventional drugs used throughout COVID-19

Widespread crops: ginger (respiratory), garlic (antiviral), turmeric (anti-inflammatory), candy wormwood (anti-SARS-CoV-2), neem (antiviral), and natural teas. Key phytoconstituents: gingerols, allicin, curcumin, artemisinins, azadirachtin. Globally, China used TCM, India used AYUSH, Madagascar promoted COVID-Organics, and South Africa used native herbs.

Regulatory itemizing in Nigeria

NAFDAC itemizing confirms security based mostly on toxicology, not efficacy. Itemizing is legitimate for 2 years; treatment claims require RCTs. Generally used treatments included lemon, ginger, garlic, turmeric, neem, pawpaw, guava, lemongrass, scent leaf, bitter leaf, detox tea, anise, and wormwood.

Gaps throughout the pandemic

Most natural mixtures lacked medical research, pharmacokinetic knowledge, and toxicological analysis. Security considerations arose for high-risk sufferers. IP legal guidelines inadequately defend conventional information. Some averted hospital care, and excessive doses might have elevated toxicity. Misinformation on social media undermined evidence-based measures.

Addressing COVID-19 by means of ethnopharmacology

Natural treatments with trial progress:

  • IHP Detox Tea (AndrographisGarciniaPsidium): Pilot RCT (n=72) confirmed no deaths (vs. 3 placebo), sooner viral clearance. Pattern too small for definitive conclusions.



  • Niprimum (Andrographis capsule): NAFDAC-listed as secure; trials deliberate.

  • FORTE1 (MoringaTerminaliaBrideliaScoparia): In vitro exercise proven; no medical trials.

HIV: α-Zam (Nigella + honey) and Jobelyn (Sorghum) confirmed symptom/CD4 enchancment in observational research with out management teams.

AMR: Crops with antibacterial properties embrace Bacopa, Andrographis, Hibiscus, and others.

Limitations

Narrative evaluate with potential choice bias. Most proof is preliminary or observational. Excessive-quality RCT knowledge are restricted. Some indigenous information could also be undocumented.

Future instructions

Key priorities: scientific validation (phytochemical, toxicogenomic, medical research); collaborative analysis involving conventional healers and scientists; coverage and IP safety; digitalisation of conventional information; and exploration of African medicinal crops towards SARS-CoV-2, Ebola, and different viruses.

Conclusions

Ethnopharmacology performed a culturally necessary function in Nigeria’s COVID-19 response. Some treatments confirmed promise, however gaps in analysis, regulation, and integration stay. Future efforts should spend money on scientific analysis, regulatory insurance policies, public consciousness, and partnerships. With the proper framework, Nigeria can combine conventional knowledge with trendy science to fight rising illnesses.

Supply:

Journal reference:

Agbamu, E., et al. (2026). Ethnopharmacology in Combating Rising Illnesses: Classes from COVID-19 in Nigeria. Journal of Exploratory Analysis in Pharmacology. DOI: 10.14218/JERP.2026.00004. https://www.xiahepublishing.com/2572-5505/JERP-2026-00004

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *